Author:
Singh Apurva,Horng Hannah,Chitalia Rhea,Roshkovan Leonid,Katz Sharyn I.,Noël Peter,Shinohara Russell T.,Kontos Despina
Abstract
AbstractOur study investigates the effects of heterogeneity in image parameters on the reproducibility of prognostic performance of models built using radiomic biomarkers. We compare the prognostic performance of models derived from the heterogeneity-mitigated features with that of models obtained from raw features, to assess whether reproducibility of prognostic scores improves upon application of our methods. We used two datasets: The Breast I-SPY1 dataset—Baseline DCE-MRI scans of 156 women with locally advanced breast cancer, treated with neoadjuvant chemotherapy, publicly available via The Cancer Imaging Archive (TCIA); The NSCLC IO dataset—Baseline CT scans of 107 patients with stage 4 non-small cell lung cancer (NSCLC), treated with pembrolizumab immunotherapy at our institution. Radiomic features (n = 102) are extracted from the tumor ROIs. We use a variety of resampling and harmonization scenarios to mitigate the heterogeneity in image parameters. The patients were divided into groups based on batch variables. For each group, the radiomic phenotypes are combined with the clinical covariates into a prognostic model. The performance of the groups is assessed using the c-statistic, derived from a Cox proportional hazards model fitted on all patients within a group. The heterogeneity-mitigation scenario (radiomic features, derived from images that have been resampled to minimum voxel spacing, are harmonized using the image acquisition parameters as batch variables) gave models with highest prognostic scores (for e.g., IO dataset; batch variable: high kernel resolution—c-score: 0.66). The prognostic performance of patient groups is not comparable in case of models built using non-heterogeneity mitigated features (for e.g., I-SPY1 dataset; batch variable: small pixel spacing—c-score: 0.54, large pixel spacing—c-score: 0.65). The prognostic performance of patient groups is closer in case of heterogeneity-mitigated scenarios (for e.g., scenario—harmonize by voxel spacing parameters: IO dataset; thin slice—c-score: 0.62, thick slice—c-score: 0.60). Our results indicate that accounting for heterogeneity in image parameters is important to obtain more reproducible prognostic scores, irrespective of image site or modality. For non-heterogeneity mitigated models, the prognostic scores are not comparable across patient groups divided based on batch variables. This study can be a step in the direction of constructing reproducible radiomic biomarkers, thus increasing their application in clinical decision making.
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. La Thangue, N. B. & Kerr, D. J. Predictive biomarkers: A paradigm shift towards personalized cancer medicine. Nat. Rev. Clin. Oncol. 8, 587–596 (2011).
2. Ding, L., Wendl, M. C., Koboldt, D. C. & Mardis, E. R. Analysis of next-generation genomic data in cancer: Accomplishments and challenges. Hum. Mol. Genet. 19(R2), R188–R196 (2010).
3. Vaidyanathan, R., Soon, R. H., Zhang, P., Jiang, K. & Lim, C. T. Cancer diagnosis: From tumor to liquid biopsy and beyond. Lab on a Chip 19(1), 11–34 (2019).
4. Kuo, M. D. & Jamshidi, N. Behind the numbers: Decoding molecular phenotypes with radiogenomics—Guiding principles and technical considerations. Radiology 270(2), 320–325 (2014).
5. O’Connor, J. P. et al. Imaging biomarker roadmap for cancer studies. Nat. Rev. Clin. Oncol. 14(3), 169–186 (2017).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献